Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twelve research firms that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $15.18.
A number of equities analysts have commented on IAS shares. Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a research note on Thursday, November 14th. Truist Financial decreased their target price on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Scotiabank started coverage on shares of Integral Ad Science in a report on Thursday. They issued a "sector perform" rating and a $10.00 price objective for the company. Piper Sandler cut their target price on shares of Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating on the stock in a research note on Wednesday, November 13th. Finally, Oppenheimer cut their price objective on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 13th.
View Our Latest Stock Analysis on Integral Ad Science
Integral Ad Science Price Performance
NASDAQ IAS traded up $0.08 on Friday, reaching $10.94. 680,547 shares of the company's stock traded hands, compared to its average volume of 1,014,679. The stock has a market cap of $1.78 billion, a PE ratio of 54.70, a P/E/G ratio of 1.53 and a beta of 1.45. Integral Ad Science has a 12 month low of $7.98 and a 12 month high of $17.53. The stock has a 50-day simple moving average of $11.11 and a 200 day simple moving average of $10.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million during the quarter, compared to the consensus estimate of $138.06 million. The firm's revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.09) earnings per share. As a group, research analysts predict that Integral Ad Science will post 0.26 earnings per share for the current year.
Insider Buying and Selling
In other Integral Ad Science news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now owns 239,709 shares in the company, valued at approximately $2,423,457.99. This represents a 4.19 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Tania Secor sold 5,240 shares of the business's stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. This represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 16,363 shares of company stock valued at $165,629 over the last 90 days. Company insiders own 2.00% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. TimesSquare Capital Management LLC grew its stake in shares of Integral Ad Science by 0.6% in the 3rd quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company's stock worth $29,970,000 after buying an additional 17,166 shares in the last quarter. abrdn plc lifted its holdings in shares of Integral Ad Science by 12.5% in the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company's stock valued at $23,216,000 after acquiring an additional 237,930 shares during the last quarter. Geode Capital Management LLC grew its position in Integral Ad Science by 6.4% in the third quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company's stock worth $19,836,000 after acquiring an additional 110,149 shares in the last quarter. Millennium Management LLC raised its position in Integral Ad Science by 10.8% during the second quarter. Millennium Management LLC now owns 1,224,138 shares of the company's stock valued at $11,899,000 after purchasing an additional 119,740 shares during the period. Finally, Crestwood Capital Management L.P. lifted its stake in shares of Integral Ad Science by 0.3% in the 3rd quarter. Crestwood Capital Management L.P. now owns 650,738 shares of the company's stock valued at $7,034,000 after purchasing an additional 1,941 shares during the last quarter. Institutional investors own 95.78% of the company's stock.
Integral Ad Science Company Profile
(
Get Free ReportIntegral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.